$ASBP Income Statement | Understand Stock

$ASBP

$8.16 -$0.64 (7.27%) Close

$ASBP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Gross Receipts
Net revenue
Cost of revenue
Gross margin
OPERATING EXPENSES
General and administrative (including stock-based compensation of $14.1 million and $0, respectively)
Aspire Biopharma Inc
Total general and administrative (including stock-based compensation of $14.1 million and $0, respectively)
Research and development
Aspire Biopharma Inc
Total research and development
Sales and marketing
Aspire Biopharma Inc
Total sales and marketing
Aspire Biopharma Inc
Total operating expenses
Loss from operations
Other income (expense):
Change in fair value of subscription loan
Interest expense – debt discount
Aspire Biopharma Inc
Total interest expense – debt discount
Interest earned on investments held in Trust Account
Interest expense
Change in fair value of liabilities
Initial recognition of forward purchase liability
Loss on extinguishment of debt
Other expense, net
Aspire Biopharma Inc
Total other expense, net
Loss before provision for income taxes
Aspire Biopharma Inc
Total loss before provision for income taxes
Income tax expense
Aspire Biopharma Inc
Total income tax expense
Net loss
Aspire Biopharma Inc
Total net loss
Weighted average shares outstanding of Common Stock, basic
Redeemable shares
Non-redeemable shares
Common Class A
Common Class B
Aspire Biopharma Inc
Total weighted average shares outstanding of Common Stock, basic

Weighted average shares outstanding of Common Stock, diluted
Redeemable shares
Non-redeemable shares
Common Class A
Common Class B
Aspire Biopharma Inc
Total weighted average shares outstanding of Common Stock, diluted

Loss per share - basic
Redeemable shares
Non-redeemable shares
Common Class A
Common Class B
Aspire Biopharma Inc

Earnings Per Share, Diluted
Redeemable shares
Non-redeemable shares
Common Class A
Common Class B
Aspire Biopharma Inc
Total earnings Per Share, Diluted

Comments